AI/ML Innovations : Introduces “The Neural Net Store”

Successful examples of this model include productivity portals such as Goole Docs and Microsoft Office, commercial portals such as eBay and Amazon, and AI-centric web portals such as ChatGPT.

These web-based transactions can be licensed either on a per-use basis by the infrequent/retail user, or by way of a subscription for frequent/commercial users.

Esmat Naikyar, CPO of AI/ML Innovations Inc, stated "With the launch of NNStore, we proudly introduce our Neural Network as a Service (NNaaS), a unique model for the development and delivery of neural network assets through cloud infrastructure.

NNStore empowers tech and developer teams in healthcare organizations to create cloud infrastructures that seamlessly integrate AI/ML's proprietary AI-driven health solutions. This service benefits a wide range of organizations, including device companies, hospitals, pharmaceuticals and many more. Additionally, healthcare teams, specialists, and researchers can directly access our solutions through the web portal, avoiding the need to develop their own integration applications.

The NNStore fundamentally eliminates barrier to adoption of AI and neural network solutions for healthcare organizations. By enabling easy implementation, it also allows organizations to leverage their anonymized historical data to uncover new insights, discover digital biomarkers, and drive faster and more efficient healthcare innovations."

###

About AI/ML Innovations Inc. https://aiml-innovations.com/

AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (95.2% owned by AIML), Tech2Heal (up to 22% ownership rights, with 12.44% currently owned by AIML), AI Rx Inc. (70% owned by AIML) and other planned accretive investments, the Company continues to capitalize on expanding growth areas, to the benefit of all the Company's stakeholders. AI/ML's shares are traded on the Canadian Securities Exchange under the symbol "AIML", the OTCQB Venture Market under "AIMLF", and the Frankfurt Stock Exchange under "42FB".

On behalf of the Board of Directors

Tim Daniels, Executive Chairman

For more information about AI/ML Innovations:

For detailed information please see AI/ML's website or the Company's filed documents at www.sedarplus.caFor further information, contact: Blake Fallis at [phone] or [e-mail]

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For AI/ML Innovations Investors

Certain statements made in this press release that are not based on historical information are forward-looking statements that involve substantial known and unknown risks and uncertainties. This press release contains express or implied forward-looking statements relating to, among other things, AI/ML Innovations' expectations concerning management's plans, objectives, and strategies, including strategies for defending the Company's intellectual property. These statements are neither promises nor guarantees but are subject to a variety of risks and uncertainties,

many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. AI/ML Innovations Inc. undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events, or circumstances or otherwise except as expressly required by applicable securities law. Further information regarding the uncertainties and risks can be found in the disclosure documents filed by AI/ML with the securities regulatory authorities, available at www.sedar.com.